Clinical Trials Directory

Trials / Conditions / Von Hippel-Lindau Syndrome

Von Hippel-Lindau Syndrome

10 registered clinical trials studyying Von Hippel-Lindau Syndrome — 1 currently recruiting.

StatusTrialSponsorPhase
Terminated68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors
NCT03001349
M.D. Anderson Cancer CenterEARLY_Phase 1
CompletedA Phase I/II Trial for Intravitreous Treatment of Severe Ocular Von Hippel-Lindau Disease Using a Combination
NCT02859441
National Eye Institute (NEI)Phase 1 / Phase 2
CompletedEvaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors
NCT01967537
National Cancer Institute (NCI)Phase 2
TerminatedTKI 258 in Von Hippel-Lindau Syndrome (VHL)
NCT01266070
M.D. Anderson Cancer CenterPhase 2
RecruitingNational Eye Institute Biorepository for Retinal Diseases
NCT01496625
National Eye Institute (NEI)—
CompletedPazopanib Hydrochloride in Treating Patients With Von Hippel-Lindau Syndrome
NCT01436227
M.D. Anderson Cancer CenterPhase 2
TerminatedSunitinib Malate to Treat Advanced Eye Disease in Patients With Von Hippel-Lindau Syndrome
NCT00673816
National Eye Institute (NEI)Phase 1 / Phase 2
TerminatedEvaluation of Sunitinib Malate in Patients With Von Hippel-Lindau Syndrome (VHL) Who Have VHL Lesions to Follo
NCT00330564
M.D. Anderson Cancer CenterPhase 2
CompletedRanibizumab Injections to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome
NCT00089765
National Eye Institute (NEI)Phase 1
CompletedGenetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 W
NCT00075348
National Institutes of Health Clinical Center (CC)—